Opinion
Video
Risk Factors and Complications Associated With Shingles
Author(s):
An expert discusses strategies for educating patients about the serious, long-term complications of shingles by using vivid, relatable language and real-life examples—emphasizing the disabling nature of postherpetic neuralgia, leveraging personal stories to increase vaccine receptivity, and reframing shingles as a pain condition rather than just a rash to prompt more meaningful prevention conversations.
When educating patients about the long-term complications of shingles, using real-life examples and relatable language can be especially effective. Rather than relying solely on statistics or generic information, discussing how complications like postherpetic neuralgia can interfere with daily activities helps make the risk more tangible. Patients often don’t understand the severity of nerve-related pain until it’s described in relatable terms—such as burning, stabbing, or shock-like sensations. These descriptors help convey that shingles isn’t just a minor rash but a condition that can cause intense, lingering pain that disrupts quality of life.
Many patients already have some familiarity with shingles through friends, family, or community members who have experienced it. These personal stories can be valuable touchpoints for starting conversations about prevention. Those who’ve seen someone suffer from complications are often more open to discussing the vaccine. For others, sharing patient experiences—like not being able to wear clothing due to pain from a shingles outbreak—can demonstrate just how debilitating the condition can be, and why vaccination is important.
When explaining the burden of shingles, it’s helpful to emphasize that the pain isn’t just temporary or mild. For some, even light contact from clothing can cause extreme discomfort, making it difficult to carry out basic tasks or leave the house. This kind of neuropathic pain may persist for months or even longer and may not respond quickly to treatment. Framing shingles as more than a rash—and instead as a potentially disabling pain condition—helps patients understand the serious impact it can have. These detailed, personalized explanations can open the door to meaningful conversations about prevention and make patients more receptive to considering the shingles vaccine.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
